These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 33795829)

  • 1. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions.
    Alexa M; Hasenburg A; Battista MJ
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Evaluation of the Diagnostic Accuracy of a Panel of Variants in
    Palles C; Fotheringham S; Chegwidden L; Lucas M; Kerr R; Mozolowski G; Rosmarin D; Taylor JC; Tomlinson I; Kerr D
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the Role of Radiotherapy for Anal Cancer.
    Dee EC; Byrne JD; Wo JY
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Immunotherapy Combination Strategies in Cancer.
    Yap TA; Parkes EE; Peng W; Moyers JT; Curran MA; Tawbi HA
    Cancer Discov; 2021 Jun; 11(6):1368-1397. PubMed ID: 33811048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study.
    Rinninella E; Strippoli A; Cintoni M; Raoul P; Vivolo R; Di Salvatore M; Genco E; Manfredi R; Bria E; Tortora G; Gasbarrini A; Pozzo C; Mele MC
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells.
    Sigala I; Koutroumani M; Koukiali A; Giannakouros T; Nikolakaki E
    Cells; 2021 Mar; 10(4):. PubMed ID: 33808326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer.
    Mehlman C; Takam Kamga P; Costantini A; Julié C; Dumenil C; Dumoulin J; Ouaknine J; Giraud V; Chinet T; Emile JF; Giroux Leprieur E
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33807552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles.
    Donizy P; Wróblewska JP; Dias-Santagata D; Woznica K; Biecek P; Mochel MC; Wu CL; Kopczynski J; Pieniazek M; Ryś J; Marszalek A; Hoang MP
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
    Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial.
    Hopkins AM; Kichenadasse G; Abuhelwa AY; McKinnon RA; Rowland A; Sorich MJ
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer.
    de Jong FC; Rutten VC; Zuiverloon TCM; Theodorescu D
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Signatures of Genomic Copy Number Variants Define Subgroups of Merkel Cell Carcinoma Tumors.
    Hill NT; Kim D; Busam KJ; Chu EY; Green C; Brownell I
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33800889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant non-small cell lung cancer harbouring MET/AXL dysregulation.
    Park K; Chang GC; Curigliano G; Lim WT; Soo RA; Molina-Vila MA; Cattan V; Darville H; Gandossi E; Smutna V; Sudey I; Viteri S
    Lung Cancer; 2021 May; 155():127-135. PubMed ID: 33798902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin.
    Barbolina MV
    Pharmacol Res; 2021 Jun; 168():105585. PubMed ID: 33798735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review.
    Agarwal N; Mangla A
    Ther Adv Hematol; 2021; 12():20406207211001139. PubMed ID: 33796239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
    Bang K; Cheon J; Jeong JH; Im HS; Kim KP; Ryoo BY; Yoo C
    Ther Adv Med Oncol; 2021; 13():17588359211003053. PubMed ID: 33796153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Client Applications and Server-Side Docker for Management of RNASeq and/or VariantSeq Workflows and Pipelines of the GPRO Suite.
    Hafez AI; Soriano B; Elsayed AA; Futami R; Ceprian R; Ramos-Ruiz R; Martinez G; Roig FJ; Torres-Font MA; Naya-Catala F; Calduch-Giner JA; Trilla-Fuertes L; Gamez-Pozo A; Arnau V; Sempere-Luna JM; Perez-Sanchez J; Gabaldon T; Llorens C
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
    Trilla-Fuertes L; Gámez-Pozo A; Maurel J; Garcia-Carbonero R; Capdevila J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Cuatrecasas M; García-Alfonso P; Ramos-Ruiz R; Llorens C; Ghanem I; Conill C; Heredia-Soto V; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Sci Rep; 2021 Apr; 11(1):7402. PubMed ID: 33795829
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.